Status:
COMPLETED
24-hour Urinary Aldosterone And Endocrine System In Obesity
Lead Sponsor:
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
Conditions:
Obesity
Brief Summary
The study was aimed at investigating the relationship between hormone parameters and urinary aldosterone levels in 24h within a cohort of overweight and obesity.
Detailed Description
Subjects were enrolled at the first examination whether they were not taking any medication, including oral contraceptives or drugs for osteoporosis, and free of significant medical illnesses, except ...
Eligibility Criteria
Inclusion
- Overweight or obesity (BMI\> 25 Kg/m2)
Exclusion
- Any kind of drug
- Hypertension
- Endocrine diseases (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism, etc.),
- Chronic inflammatory diseases
- Renal failure
- Liver failure
- Angina pectoris
- Myocardial infarction and heart failure
- Genetic heart diseases
- Thrombocytopenias
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT04354285
Start Date
January 1 2019
End Date
December 1 2019
Last Update
April 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Gastroenterology IRCCS S. de Bellis
Castellana Grotte, Bari, Italy, 70132